PPA
AXDX

Parametric Portfolio Associates’s Accelerate Diagnostics AXDX Stock Holding History

Parametric Portfolio Associates’s Portfolio AXDX Stock Details AXDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$328K Buy
22,790
+17,785
+355% +$506K ﹤0.01% 3246
2021
Q4 		$261K Sell
5,005
-445
-8% -$24.8K ﹤0.01% 3325
2021
Q3 		$318K Sell
5,450
-57
-1% -$3.72K ﹤0.01% 3275
2021
Q2 		$444K Buy
5,507
+4,109
+294% +$327K ﹤0.01% 3135
2021
Q1 		$116K Buy
1,398
+28
+2% +$2.84K ﹤0.01% 3955
2020
Q4 		$104K Sell
1,370
-2,863
-68% -$256K ﹤0.01% 3883
2020
Q3 		$451K Sell
4,233
-67
-2% -$9.3K ﹤0.01% 3324
2020
Q2 		$652K Sell
4,300
-409
-9% -$40.3K ﹤0.01% 3140
2020
Q1 		$392K Sell
4,709
-1,141
-20% -$161K ﹤0.01% 3292
2019
Q4 		$989K Buy
5,850
+63
+1% +$10.4K ﹤0.01% 3063
2019
Q3 		$1.07M Sell
5,787
-468
-7% -$90.5K ﹤0.01% 2982
2019
Q2 		$1.43M Buy
6,255
+1,310
+26% +$256K ﹤0.01% 2859
2019
Q1 		$1.04M Buy
4,945
+893
+22% +$167K ﹤0.01% 3013
2018
Q4 		$466K Buy
4,052
+533
+15% +$79K ﹤0.01% 3344
2018
Q3 		$808K Sell
3,519
-61
-2% -$13.5K ﹤0.01% 3210
2018
Q2 		$798K Buy
3,580
+516
+17% +$115K ﹤0.01% 3160
2018
Q1 		$700K Buy
3,064
+17
+0.6% +$4.46K ﹤0.01% 3188
2017
Q4 		$798K Buy
3,047
+219
+8% +$51.3K ﹤0.01% 3126
2017
Q3 		$635K Buy
2,828
+534
+23% +$131K ﹤0.01% 3294
2017
Q2 		$627K Buy
2,294
+47
+2% +$12.7K ﹤0.01% 3231
2017
Q1 		$544K Sell
2,247
-171
-7% -$39.1K ﹤0.01% 3161
2016
Q4 		$502K Buy
2,418
+49
+2% +$11.6K ﹤0.01% 3192
2016
Q3 		$646K Buy
2,369
+266
+13% +$58.9K ﹤0.01% 3043
2016
Q2 		$303K Sell
2,103
-20
-0.9% -$2.68K ﹤0.01% 3449
2016
Q1 		$305K Buy
+2,123
New +$300K ﹤0.01% 3598

Other funds holding AXDX

OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $214M AUM 185.33% 1-Year Est. Return
Baird Financial Group
Baird Financial Group Milwaukee, Wisconsin $72.7B AUM 26.4% 1-Year Est. Return
GAM
Griffin Asset Management New York $949M AUM 24.98% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CC
Cannell & Co New York $3.15B AUM 30.62% 1-Year Est. Return
Axa
Axa Paris, France $91.9M AUM 27.41% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return

Parametric Portfolio Associates's AXDX Position: Q1 2022 in Review

Parametric Portfolio Associates increased its Accelerate Diagnostics (AXDX) stake by 355% in Q1 2022, buying an estimated $506K and bringing the position to 22,790 shares worth $328K. The position accounts for ﹤0.01% of the portfolio, ranked #3246.

Parametric Portfolio Associates first reported a position in AXDX in Q1 2016 and has held it in 25 quarters since. The position peaked at $1.43M in Q2 2019. 106 funds tracked by Wall St. Rank hold AXDX as of Q1 2022.

  • Parametric Portfolio Associates held 22,790 shares of Accelerate Diagnostics worth $328K as of Q1 2022.
  • Parametric Portfolio Associates bought 17,785 Accelerate Diagnostics shares in Q1 2022, an estimated $506K.
  • Accelerate Diagnostics made up ﹤0.01% of Parametric Portfolio Associates's portfolio in Q1 2022, its #3246 holding.
  • Parametric Portfolio Associates first reported a position in Accelerate Diagnostics in Q1 2016 and has held it in 25 quarters since.
  • Parametric Portfolio Associates's Accelerate Diagnostics position peaked at $1.43M in Q2 2019.
  • 106 funds tracked by Wall St. Rank held Accelerate Diagnostics as of Q1 2022.

Based on Parametric Portfolio Associates's 13F filing for Q1 2022, filed 16 May 2022.